<paragraph> Vasa Denticity's financial statements are clean on their face, with unqualified audit opinions and no red flags in CARO responses across all reported years. However, the company's reported profit is not converting to cash, with cumulative CFO negative ₹40 crore against ₹42 crore of core PAT over three years, and the promoter group's stake has fallen 5.78 percentage points in one year amid leadership exits. </paragraph>
Key findings
- Reported profit is not converting to cash
Major- Cumulative CFO over three years was negative ₹40 crore against cumulative PAT of ₹42 crore (excluding other income of ₹8 crore), a CFO/PAT ratio of -1.18x. FY26 CFO was negative ₹25.09 crore against PAT of ₹9.91 crore, a CFO/PAT ratio of -2.53x. Receivables days improved from 23.93 in FY24 to 20.31 in FY25 to 15.77 in FY26. - Promoter shareholding fell 5.78 percentage points in one year
Major- Promoter shareholding declined from 65.97% to 60.19% of paid-up capital between FY2025 and FY2026, with pledge level at 0.00% in both periods. Promoters Manish Kumar (254,250 shares, 1.53%) and Nakul Varshney (174,500 shares, 1.05%) applied on August 11, 2025 for reclassification to 'Public' category under Regulation 31A of SEBI LODR. The company sought shareholder approval on October 7, 2025, following NSE No Objection dated September 12, 2025. - Vasa Denticity built a three-subsidiary group in two years
Major- The company had no subsidiary as of FY2021-22, acquired 100% of Waldent Innovation during FY2022-23, and as of FY2025-26 has three subsidiaries: Waldent Innovations (100%), Smileworks (60%), and Dentalkart Distribution UK (51%). The UK entity, incorporated May 21, 2025, had no turnover as of March 31, 2026, with first statutory statements due by February 21, 2027. Consolidated PAT for the latest FY was ₹11.28 crore versus standalone PAT of ₹12.10 crore. - The only current related-party lending is a working-capital loan to a 60% subsidiary
Minor- Vasa Denticity extended a loan of ₹1.65 crore to Smileworks Private Limited during FY2025-26, earning interest of ₹14.60 lakh at 8% p.a. for working capital purposes. Advances of ₹85.83 lakh to Smileworks and ₹0.25 lakh to Waldent Innovations were outstanding during FY2025-26. Related party transactions with promoter-linked sole proprietorships ended during FY2023-24, and their business operations ceased. - Statutory auditor resigned mid-tenure in FY2022-23, replacement has served since
Minor- M/s TATTVAM & Co. resigned as statutory auditor on October 30, 2022, citing "preoccupation in other assignments." M/s KRA & Co. was appointed effective November 07, 2022 to fill the casual vacancy, and was later appointed for five consecutive years at the Seventh AGM, with tenure concluding at the Twelfth AGM (FY2027-28). The Independent Auditor's Report for FY2021-22 states that "issues, objections and concerns of outgoing auditor" were considered. - Audit opinions and CARO responses are clean across all reported years
Minor- The statutory auditor issued unqualified opinions on both standalone and consolidated financial statements for FY2025-26, with no Key Audit Matters identified. The consolidated audit included one subsidiary audited by another auditor (revenue ₹296.00 Lacs, net loss ₹82.66 Lacs) and one unaudited subsidiary certified by management (revenue Nil, net cash inflow ₹118.23 Lacs), with the opinion not modified. CARO clause (iii)(a) discloses a loan to a subsidiary of ₹1.65 crore during the year, with outstanding balance of ₹2.47 crore as at 31 March 2026.
What to watch
- UK subsidiary's first statutory statements. Due by February 21, 2027, which will reveal the entity's initial operating results.
- Shareholder vote on promoter reclassification. Sought on October 7, 2025, with outcome pending.
- Statutory auditor's term conclusion. KRA & Co.'s five-year term ends at the Twelfth AGM (FY2027-28), with reappointment decision to be taken then.
- Independent director resignation. Ravi Parmeshwar's resignation effective August 07, 2026, with no material reasons provided.
Bottom line: Vasa Denticity's audit record is clean, with unqualified opinions and no CARO red flags, and the related-party lending is limited to a disclosed working-capital loan to a subsidiary. The core concern is cash conversion: cumulative CFO of negative ₹40 crore against ₹42 crore of core PAT over three years, alongside a 5.78 percentage point drop in promoter stake and a rapid three-subsidiary expansion including a UK entity with no turnover. Watch the UK subsidiary's first statements, the promoter reclassification vote, and the auditor's term conclusion.